Gabapentinoids: repeating mistakes of the past? [Editorial]

B. MURNION ; A. SCHAFFER ; R. CAIRNS ; J. BRETT | 2022
Dans Addiction (Vol.117, n°12, December 2022) Article : Périodique

Gabapentinoid abuse and harms are increasing proportional to increased prescribing. Despite early indicators of problems and similar patterns with other drugs, regulatory controls over promotion and availability were introduced only after signif[...]

Plus d'info

Ajouter à la sélection

Lien externe

Understandings, attitudes, practices and responses to GHB overdose among GHB consumers

J. FREESTONE ; N. EZARD ; A. BOURNE ; J. BRETT ; D. M. ROBERTS ; M. HAMMOUD ; A. NEDANOSKI ; G. PRESTAGE ; K. J. SIEFRIED | 2023
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique

BACKGROUND: Gamma-hydroxybutyrate (GHB) is used at disproportionately high rates within sexuality and gender diverse communities and carries a high risk of overdose. GHB overdose can result in death. Internationally, recent increases in GHB over[...]

Plus d'info

Ajouter à la sélection

Lien externe